Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016 (2016), Article ID 9858374, 12 pages
http://dx.doi.org/10.1155/2016/9858374
Research Article

Regulation of IL-33 by Oncostatin M in Mouse Lung Epithelial Cells

McMaster Immunology Research Centre, Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada

Received 21 June 2016; Revised 12 August 2016; Accepted 17 August 2016

Academic Editor: Alex Kleinjan

Copyright © 2016 Carl D. Richards et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Onda, H. Kasuya, K. Takakura et al., “Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage,” Journal of Cerebral Blood Flow and Metabolism, vol. 19, no. 11, pp. 1279–1288, 1999. View at Google Scholar · View at Scopus
  2. E. S. Baekkevold, M. Roussigné, T. Yamanaka et al., “Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules,” American Journal of Pathology, vol. 163, no. 1, pp. 69–79, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Schmitz, A. Owyang, E. Oldham et al., “IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines,” Immunity, vol. 23, no. 5, pp. 479–490, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-I. Tominaga, “A putative protein of a growth specific cDNA from BALB/C-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor,” FEBS Letters, vol. 258, no. 2, pp. 301–304, 1989. View at Publisher · View at Google Scholar · View at Scopus
  5. F. Y. Liew, N. I. Pitman, and I. B. McInnes, “Disease-associated functions of IL-33: the new kid in the IL-1 family,” Nature Reviews Immunology, vol. 10, no. 2, pp. 103–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Haraldsen, J. Balogh, J. Pollheimer, J. Sponheim, and A. M. Küchler, “Interleukin-33 - cytokine of dual function or novel alarmin?” Trends in Immunology, vol. 30, no. 5, pp. 227–233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. A. B. Molofsky, A. K. Savage, and R. M. Locksley, “Interleukin-33 in tissue homeostasis, injury, and inflammation,” Immunity, vol. 42, no. 6, pp. 1005–1019, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Miller, “Role of IL-33 in inflammation and disease,” Journal of Inflammation, vol. 8, article 22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Chackerian, E. R. Oldham, E. E. Murphy, J. Schmitz, S. Pflanz, and R. A. Kastelein, “IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex,” Journal of Immunology, vol. 179, no. 4, pp. 2551–2555, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Bessa, C. A. Meyer, M. C. de Vera Mudry et al., “Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation,” Journal of Autoimmunity, vol. 55, no. 1, pp. 33–41, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. V. Carriere, L. Roussel, N. Ortega et al., “IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 1, pp. 282–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ali, A. Mohs, M. Thomas et al., “The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription,” Journal of Immunology, vol. 187, no. 4, pp. 1609–1616, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Stolarski, M. Kurowska-Stolarska, P. Kewin, D. Xu, and F. Y. Liew, “IL-33 exacerbates eosinophil-mediated airway inflammation,” The Journal of Immunology, vol. 185, no. 6, pp. 3472–3480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Llop-Guevara, D. K. Chu, T. D. Walker et al., “A GM-CSF/IL-33 pathway facilitates allergic airway responses to sub-threshold house dust mite exposure,” PLoS ONE, vol. 9, no. 2, Article ID e88714, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Oboki, T. Ohno, N. Kajiwara et al., “IL-33 is a crucial amplifier of innate rather than acquired immunity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 43, pp. 18581–18586, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. I. G. Luzina, E. M. Pickering, P. Kopach et al., “Full-length IL-33 promotes inflammation but not Th2 response in vivo in an ST2-independent fashion,” The Journal of Immunology, vol. 189, no. 1, pp. 403–410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. I. G. Luzina, P. Kopach, V. Lockatell et al., “Interleukin-33 potentiates Bleomycin-induced lung injury,” American Journal of Respiratory Cell and Molecular Biology, vol. 49, no. 6, pp. 999–1008, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Li, R. Guabiraba, A.-G. Besnard et al., “IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice,” Journal of Allergy and Clinical Immunology, vol. 134, no. 6, pp. 1422–1432, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Moussion, N. Ortega, and J.-P. Girard, “The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel ‘Alarmin’?” PLoS ONE, vol. 3, no. 10, Article ID e3331, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Pichery, E. Mirey, P. Mercier et al., “Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain,” Journal of Immunology, vol. 188, no. 7, pp. 3488–3495, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Ohno, K. Oboki, N. Kajiwara et al., “Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages,” Journal of Immunology, vol. 183, no. 12, pp. 7890–7897, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Préfontaine, S. Lajoie-Kadoch, S. Foley et al., “Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells,” Journal of Immunology, vol. 183, no. 8, pp. 5094–5103, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Kopach, V. Lockatell, E. M. Pickering et al., “IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism,” The Journal of Biological Chemistry, vol. 289, no. 17, pp. 11829–11843, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. A. G. Bruce, P. S. Linsley, and T. M. Rose, “Oncostatin M,” Progress in Growth Factor Research, vol. 4, no. 2, pp. 157–170, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Miyajima, T. Kinoshita, M. Tanaka, A. Kamiya, Y. Mukouyama, and T. Hara, “Role of oncostatin M in hematopoiesis and liver development,” Cytokine and Growth Factor Reviews, vol. 11, no. 3, pp. 177–183, 2000. View at Publisher · View at Google Scholar · View at Scopus
  26. C. D. Richards, “The enigmatic cytokine oncostatin m and roles in disease,” ISRN Inflammation, vol. 2013, Article ID 512103, 23 pages, 2013. View at Publisher · View at Google Scholar
  27. H. M. Hermanns, “Oncostatin M and interleukin-31: cytokines, receptors, signal transduction and physiology,” Cytokine and Growth Factor Reviews, vol. 26, no. 5, pp. 545–558, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Simpson, K. J. Baines, M. J. Boyle, R. J. Scott, and P. G. Gibson, “Oncostatin M (OSM) is increased in asthma with incompletely reversible airflow obstruction,” Experimental Lung Research, vol. 35, no. 9, pp. 781–794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Mozaffarian, A. W. Brewer, E. S. Trueblood et al., “Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis,” Journal of Immunology, vol. 181, no. 10, pp. 7243–7253, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. K. Fritz, C. Kerr, R. Fattouh et al., “A mouse model of airway disease: oncostatin M-induced pulmonary eosinophilia, goblet cell hyperplasia, and airway hyperresponsiveness are STAT6 dependent, and interstitial pulmonary fibrosis is STAT6 independent,” Journal of Immunology, vol. 186, no. 2, pp. 1107–1118, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Wong, F. M. Botelho, R. M. Rodrigues, and C. D. Richards, “Oncostatin M overexpression induces matrix deposition, STAT3 activation, and SMAD1 dysregulation in lungs of fibrosis-resistant BALB/c mice,” Laboratory Investigation, vol. 94, no. 9, pp. 1003–1016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. D. S. Faffe, L. Flynt, M. Mellema et al., “Oncostatin M causes eotaxin-1 release from airway smooth muscle: synergy with IL-4 and IL-13,” Journal of Allergy and Clinical Immunology, vol. 115, no. 3, pp. 514–520, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. I. Arshad, P. Guihard, Y. Danger et al., “Oncostatin M induces IL-33 expression in liver endothelial cells in mice and expands ST2+CD4+ lymphocytes,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 309, no. 7, pp. G542–G553, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. O. Sundnes, W. Pietka, T. Loos et al., “Epidermal expression and regulation of interleukin-33 during homeostasis and inflammation: strong species differences,” Journal of Investigative Dermatology, vol. 135, no. 7, pp. 1771–1780, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. J. J. O'Donoghue, D. A. Knight, C. D. Richards et al., “Genetic partitioning of interleukin-6 signalling in mice dissociates Stat3 from Smad3-mediated lung fibrosis,” EMBO Molecular Medicine, vol. 4, no. 9, pp. 939–951, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Saleh, D. Eeles, J. M. Hodge et al., “Interleukin-33, a target of parathyroid hormone and oncostatin m, increases osteoblastic matrix mineral deposition and inhibits osteoclast formation in vitro,” Endocrinology, vol. 152, no. 5, pp. 1911–1922, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Rani, A. G. Smulian, D. R. Greaves, S. P. Hogan, and D. R. Herbert, “TGF-β limits IL-33 production and promotes the resolution of colitis through regulation of macrophage function,” European Journal of Immunology, vol. 41, no. 7, pp. 2000–2009, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Lefrançais, S. Roga, V. Gautier et al., “IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 5, pp. 1673–1678, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. U. Lüthi, S. P. Cullen, E. A. McNeela et al., “Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases,” Immunity, vol. 31, no. 1, pp. 84–98, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Le Goffic, M. I. Arshad, M. Rauch et al., “Infection with influenza virus induces IL-33 in murine lungs,” American Journal of Respiratory Cell and Molecular Biology, vol. 45, no. 6, pp. 1125–1132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Kearley, J. S. Silver, C. Sanden et al., “Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection,” Immunity, vol. 42, no. 3, pp. 566–579, 2015. View at Publisher · View at Google Scholar · View at Scopus